Vorinostat and bortezomib as third-line therapy in patients with advanced non-small cell lung cancer: A Wisconsin Oncology Network Phase II study
Tien Hoang, Toby C. Campbell, Chong Zhang, Kyung Mann Kim, Jill M. Kolesar, Kurt R. Oettel, Jules H. Blank, Emily G. Robinson, Harish G. Ahuja, Ron J. Kirschling, Peter H. Johnson, Michael S. Huie, Mary E. Wims, Martha M. Larson, Hilary R. Hernan, Anne M. Traynor
Research output: Contribution to journal › Article › peer-review
36Scopus
citations
Fingerprint
Dive into the research topics of 'Vorinostat and bortezomib as third-line therapy in patients with advanced non-small cell lung cancer: A Wisconsin Oncology Network Phase II study'. Together they form a unique fingerprint.